Report / Paper metadata
Long noncoding RNA associations with an IFI27–MCEMP1 transcript pattern in Kawasaki disease
A single-hospital study found differences in selected blood-cell RNA measurements between children with Kawasaki disease and other febrile illnesses. The findings describe an associated transcript pattern, not a demonstrated disease mechanism or a new clinically proven diagnostic test.
Who and what were studied?
The newly enrolled cohort included 55 children with Kawasaki disease and 48 febrile controls, all younger than eight, at one hospital in Shanghai. Combining this group with two earlier cohorts from the same hospital produced 188 children with Kawasaki disease and 175 controls. The integrated cohort includes the new cohort; these are not separate populations that should be added together again.
What do the measurements mean?
Researchers used reverse-transcription quantitative PCR on bulk peripheral blood mononuclear cells to measure IFI27, MCEMP1 and three selected long noncoding RNAs: CHROMR, MALAT1 and NEAT1. Bulk measurements combine signals from different cell types. A difference can reflect cell proportions, expression within cells or both, and does not by itself identify an active pathway.
How did the existing score perform?
The prespecified IFI27–MCEMP1 score had an area under the receiver operating characteristic curve of 0.88 in the new cohort and 0.89 in the integrated cohort. The score and threshold were not refitted. These values describe discrimination between the study groups, not the percentage of children diagnosed correctly or proof that the score improves clinical decisions. The exploratory RNA analyses did not test added diagnostic value.
Which associations survived closer checks?
Lower CHROMR and IFI27 expression and higher MCEMP1 expression remained significant after adjustment for fever duration and a broad blood-count-derived monocyte fraction. The MALAT1 difference weakened, while NEAT1 did not show a significant group difference. CHROMR and IFI27 were correlated in the unadjusted integrated analysis, but the correlation was not significant in the restricted fever-day-matched analysis. A robust group difference and a robust within-pattern correlation are different claims.
What limits the biological interpretation?
The matched analysis had limited overlap in fever timing and a small effective sample. Blood counts could address broad monocyte-versus-lymphocyte composition, not specific cell populations. Rechecking CHROMR amplification efficiency supported the main association, but archived gel or sequencing evidence was unavailable to confirm the amplified product. No functional experiments here established that CHROMR regulates IFI27 or causes vascular injury.
What remains to be demonstrated?
The study did not measure pathway activity, cell-resolved expression, vascular tissue or incremental clinical utility. Multiple-centre replication, standardized sampling and independent assay confirmation are needed. This original full-text explanation preserves the distinction between RNA abundance, statistical association, mechanism and patient-facing diagnostic value.
- Kind
- Paper metadata
- Identifier
- PMC13642318